The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Child Pugh Score
Timeframe: 1 month after injection
Child Pugh Score
Timeframe: 3 months after injection
Child Pugh Score
Timeframe: 6 months after injection
Examination of liver function
Timeframe: 1 month after injection
Examination of liver function
Timeframe: 3 months after injection
Examination of liver function
Timeframe: 6 months after injection
MELD Score
Timeframe: 1 month after injection
MELD Score
Timeframe: 3 months after injection
MELD Score
Timeframe: 6 months